Donor CHIP and Allogeneic HSCT Outcome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Donor CHIP and Allogeneic HSCT Outcome — Stella

Home/Clonal Hematopoiesis/

View on ClinicalTrials.gov

Recruiting

Back to Clonal Hematopoiesis trials

Trial locations(1 site)

Hong Kong

The University of Hong Kong, Hong Kong

Key details

Sponsor

The University of Hong Kong

Enrollment target

~850 participants

Started

January 2021

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated October 2022

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.